Vascular Therapies Completes Enrollment In ACCESS 2 Study
05 Aug 2024 //
ACCESSWIRE
Vascular Therapies Announces Presentation of Phase 3 Clinical Trial Results ASH
04 Nov 2021 //
PRNEWSWIRE
05 Aug 2024 //
ACCESSWIRE
04 Nov 2021 //
PRNEWSWIRE